Immunoprophylaxis of viral hepatitis: a practical guide. NLM AIDSLINE Important note: Information in this article was accurate in 1987. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Immunoprophylaxis of viral hepatitis: a practical guide.

Am J Gastroenterol. 1987 Apr;82(4):287-91. Unique Identifier : AIDSLINE MED/87181594
Schiff ER

Abstract: There are presently available immune globulin preparations of proven efficacy and safety in the prophylaxis of type A and B viral hepatitis. Active vaccines for prevention of type B hepatitis are now available and are safe and effective. None of these preparations has been associated with the development of HTLV-III/LAV/HIV infection. Preexposure prophylaxis for type B hepatitis is indicated for health care workers who have frequent contact with blood, and most endoscopists would be among this group of high-risk individuals. Prenatal screening of pregnant women for HBsAg provides an opportunity to intervene in the vicious cycle of perpetuating a population of hepatitis B carriers via perinatal transmission. Unfortunately until serological tags for the non-A non-B hepatitis viruses are identified, there will be no effective vaccination for this form of hepatitis. Patients who already have acute or chronic viral hepatitis must await the advent of safe and effective antiviral agents for treatment of these viral infections.
Keywords: Female Hepatitis A/PREVENTION & CONTROL Hepatitis B/PREVENTION & CONTROL *Hepatitis B Virus Hepatitis C/PREVENTION & CONTROL Hepatitis, Viral, Human/ETIOLOGY/*PREVENTION & CONTROL *Hepatovirus Human *Immunization Pregnancy Risk Viral Hepatitis Vaccines/*ADMINISTRATION & DOSAGE JOURNAL ARTICLE

KWDfemalehepatitisa/prevention&controlhepatitisb/prevention&controlKWDhepatitisbvirushepatitisc/prevention&controlhepatitis,viral,human/etiology/KWDprevention&controlKWDhepatovirushumanKWDimmunizationpregnancyriskviralhepatitisvaccines/KWDadministration&dosagejournalarticle
870730
M8770060

Copyright © 1987 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1987. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1987. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .